Leading Kidney Care Platform

2021-2025 outlook on other items Debt Expense Higher rates due to increasing benchmark Tax Rate Assumed effective tax rate of 25% to 27% Non-controlling Interest Expected to grow with US Dialysis Operating Income Share Repurchases Consistent standards - expect continued use of a significant portion of FCF for share repurchases Other Income/ (Loss) No net impact expected 53 © 2021 DaVita Inc. All rights reserved. *

View entire presentation